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GABAA receptors are the main fast inhibitory neurotransmitter receptors in the mammalian
brain, and targets formany clinically important drugswidely used in the treatment of anxiety
disorders, insomnia and in anesthesia. Nonetheless, there are signiﬁcant risks associated
with the long-term use of these drugs particularly related to development of tolerance
and addiction. Addictive mechanisms of GABAA receptor drugs are poorly known, but
recent ﬁndings suggest that those drugs may induce aberrant neuroadaptations in the
brain reward circuitry. Recently, benzodiazepines, acting on synaptic GABAA receptors,
and modulators of extrasynaptic GABAA receptors (THIP and neurosteroids) have been
found to induce plasticity in the ventral tegmental area (VTA) dopamine neurons and their
main target projections. Furthermore, dependingwhether synaptic or extrasynaptic GABAA
receptor populations are activated, the behavioral outcome of repeated administration
seems to correlate with rewarding or aversive behavioral responses, respectively.The VTA
dopamine neurons project to forebrain centers such as the nucleus accumbens and medial
prefrontal cortex, and receive afferent projections from these brain regions and especially
from the extended amygdala and lateral habenula, forming themajor part of the reward and
aversion circuitry. Both synaptic and extrasynaptic GABAA drugs inhibit theVTA GABAergic
interneurons, thus activating the VTA DA neurons by disinhibition and this way inducing
glutamatergic synaptic plasticity. However, the GABAA drugs failed to alter synaptic spine
numbers as studied from Golgi-Cox-stained VTA dendrites. Since the GABAergic drugs
are known to depress the brain metabolism and gene expression, their likely way of
inducing neuroplasticity in mature neurons is by disinhibiting the principal neurons, which
remains to be rigorously tested for a number of clinically important anxiolytics, sedatives
and anesthetics in different parts of the circuitry.
Keywords: GABAA receptor, benzodiazepines,THIP, neurosteroids, dopamine neurons, neuroadaptation, dendritic
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INTRODUCTION
GABAA receptor agonists generally depress brain activity. Ben-
zodiazepines (BZs) and other GABAmimetic drugs depress gene
expression in the brain, including the neuroplasticity-related genes
such as brain-derived neurotrophic factor (BDNF), nerve growth
factor (NGF), and Fos-genes (Zafra et al., 1991; Huopaniemi
et al., 2004). BZs and volatile anesthetic isoﬂurane also have
been reported to reduce long-term potentiation (LTP) in several
brain regions (Higashima et al., 1998; Kulisch et al., 2011; Piao
et al., 2013). Moreover, BZs and general anesthetics are able to
impair neurogenesis in both young and adult animals (Wu and
Castren, 2009; Erasso et al., 2013; Thal et al., 2014). All these
facts suggest that GABAA receptor agonists have little potential
for neuroplasticity outside the critical periods of brain develop-
ment, when the role of GABAergic interneurons is obligatory
(Hensch and Stryker, 2004). On the other hand, by suppressing
the local inhibitory regulation, GABAA receptors on GABAergic
interneurons can indirectly cause activation of principal neuron
populations, a network effect called disinhibition. For example,
GABAergic neurons in the lateral part of the central nucleus of
amygdala are excited by low acute doses of BZs through disin-
hibition and this is associated with anxiolytic effects (Beck and
Fibiger, 1995; Salminen et al., 1996; Panhelainen and Korpi, 2012).
Furthermore, GABAA receptor agonists can activate the dopamin-
ergic (DAergic) neurons in the ventral tegmental area (VTA) by
disinhibition (Heikkinen et al., 2009; Tan et al., 2010;Vashchinkina
et al., 2012).
In this review we will discuss recent advances in under-
standing how GABAA receptor modulators affect both GABAer-
gic and glutamatergic synapses and also how their acute or
repeated treatments can modulate plasticity of the reward
system. Given the widespread application of GABAA recep-
tor drugs, understanding more fully how they modulate
brain reward system may help to develop new strategies for
designing novel compounds to overcome their therapeutic
limitations.
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GABAA RECEPTORS AND THEIR MODULATORS
Benzodiazepines, inhalational and intravenous anesthetics, barbi-
turates, neurosteroids, and other GABAmimetic drugs – all share
the interaction with the GABAA receptor and facilitation of recep-
tor function to produce strong pharmacological and behavioral
actions (Sieghart, 1995; Korpi et al., 2002). They act on distinct
sites on the GABAA receptor and increase membrane anion (Cl−
and bicarbonate) conductance, thereby in most cases inducing
hyperpolarization, which has an inhibitory effect on the ﬁring of
the postsynaptic neurons.
The GABAA receptors belong to the “cys-loop” superfam-
ily of ligand-gated ion channels (Alexander et al., 2013). They
exist as heteropentameric structures, commonly composed of
two α subunits, two β subunits, and one γ or δ subunit
(McKernan and Whiting, 1996). The BZ-sensitive GABAA recep-
tors contain either α1, α2, α3, and/or α5 subunits and as a
result of containing the γ2 subunit, they are preferentially located
at synaptic sites (with the exception of α5), whereas the α4
or α6 subunit-containing GABAA receptors are highly sensitive
to neurosteroids, GABAmimetic drugs such as muscimol and
THIP (gaboxadol; 4,5,6,7-tetrahydroisoxazolol[4,5-c]pyridine-3-
ol), general anesthetics such as isoﬂurane and etomidate. Since
they often possess the δ subunit instead of γ2, they are located at
peri- or extrasynaptic sites (Olsen and Sieghart, 2009).
GABAA receptor modulators are effective in the wide range of
indications (anxiety disorders, panic, insomnia, muscle spams,
seizure control in epilepsy and alcohol withdrawal, sedation
of aggressive patients, calming down anxious patients before
operations, and induction of anesthesia) by acting on distinct
GABAA receptor subtypes which demonstrate a unique hetero-
geneity in terms of function, kinetics, pharmacological proﬁle,
and distribution in brain (Uusi-Oukari and Korpi, 2010). Com-
bination of pharmacological and genetic approaches has revealed
that 1) α1 subunit-containing GABAA receptors mainly mediate
the sedative and addictive effects of BZs, 2) α2 or α3 subunit-
containing receptors mediate the anxiolytic and muscle-relaxant
effects, and 3) α5 subunit-containing receptors mediate the
memory-impairing effects of BZs (Crestani et al., 1999; Rudolph
and Mohler, 2004). Furthermore, there is growing evidence that
hippocampal extrasynaptic α5 subunit-containing receptors con-
tribute to amnestic effects by general anesthetics (Grasshoff et al.,
2005), while the stimulation of δ subunit-containing receptors
mediate anxiolytic, anticonvulsive, anesthetic, and aversive effects
of neurosteroids in mice (Mihalek et al., 1999; Vashchinkina et al.,
2014).
Despite the usefulness of GABAA receptor modulators, their
use may lead to side-effects that limit their efﬁcacy. General anes-
thetics may induce postoperative cognitive dysfunction for weeks
or months in elderly patients (Canet et al., 2003; Newman et al.,
2007), and their use in prolonged operations at neonatal period,
although necessary, have raised serious thoughts about possi-
ble neuronal damage and long-term cognitive effects as seen in
preclinical models (Jevtovic-Todorovic et al., 2013). Beside the
short-term undesirable effects of BZs such as dizziness and motor
impairment, their long-term effects include disruption of sleep
architecture, confusion and memory impairment, tolerance and
dependence (Licata and Rowlett, 2008). Furthermore, chronic
increased exposure to neurosteroids appears to accelerate develop-
ment of Alzheimer’s disease symptoms in various mouse models
(Bengtsson et al., 2012, 2013). Thus, the use of these drugs causes
persistent neuroadaptation in the brain that also may contribute
to adverse effects.
GABAA DRUGS IN THE ANIMAL MODELS OF ADDICTION
Addiction is increasingly seen as a disease of aberrant neuroadap-
tation in the brain reward system (Volkow and Baler, 2014). The
VTA dopamine neurons are considered as an essential hub at least
for the early phases of addiction. VTA has reciprocal connections
with many forebrain centers such as the nucleus accumbens (NAc,
ventral striatum), dorsal striatum, the medial prefrontal cortex
(mPFC), the extended amygdala (particularly including the baso-
lateral (BLA) and central nuclei of amygdala and the bed nuclei of
stria terminalis) and lateral habenula, which circuitries form the
major part of reward and aversion pathways.
The risk of developing addiction is one of the main challenges
restricting the clinical use of BZs and other GABAA modula-
tors (O’Brien, 2005). Addiction-related behaviors can also be
studied in experimental animal models. Drugs of abuse acti-
vate the reward system and produce reinforcing effects in drug
self-administration, in potentiation of the intracranial electrical
self-stimulation reward, and in drug-induced learning and con-
ditioning. Various non-selective BZ agonists, such as diazepam
and midazolam, are self-administered (Tan et al., 2010). They
are rewarding in conditioned place preference paradigm (Spyraki
et al., 1985) and able to increase the rate of responding for
and to decrease the threshold of the intracranial self-stimulation
reward (Straub et al., 2010). The α1 subunit-preferring ago-
nist zolpidem is self-administered in baboons (Ator, 2002), but
produces no place preference in rats (Meririnne et al., 1999),
showing thus somewhat unclear effects. This might be due to
zolpidem’s strong dose-dependent sedative effect. The α2 subunit-
containing GABAA receptors in the NAc were necessary for the
midazolam preference in a test giving the mice a choice between
sucrose solution and sucrose/midazolam solution (Engin et al.,
2014). The endogenous neurosteroid GABAA agonist allopreg-
nanolone displays variable effects in animal models of addiction.
It can maintain oral self-administration, although not in oper-
ant setting (Sinnott et al., 2002). It decreases the threshold of
the intracranial self-stimulation reward (Fish et al., 2014), and
when injected intraperitoneally (ip), it has been shown to induce
either rewarding (Finn et al., 1997) or aversive conditioning
effects (Beauchamp et al., 2000). Propofol is rewarding in condi-
tioned place preference (Pain et al., 1996), while isoﬂurane and
GABAA β2/3 subunit-selective etomidate have not been tested
so far.
In attempts to further localize the reward-related effects of
GABAA modulators in brain circuitry, intracerebral drug infusions
have been used. GABAA agonist muscimol and antagonist bicu-
culline show interesting effects as they both are reinforcing and
rewarding in drug-naïve animals when infused into the VTA (Ike-
moto et al., 1997, 1998; Laviolette and van der Kooy, 2001). These
results have been explained as effects arising from two reward
systems, one being DAergic and the other non-DAergic. Musci-
mol is believed to inhibit VTA GABA neurons and thus disinhibit
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VTA DA neurons leading to DA antagonist-sensitive reward, while
bicuculline also acts on VTA GABA neurons but activates them
to target a poorly deﬁned non-DAergic reward pathway insen-
sitive to DA receptor antagonists (Laviolette and van der Kooy,
2001). It remains to be studied, e.g., whether bicuculline acts on
VTA GABA neurons projecting to NAc cholinergic interneurons,
thereby potentiating appetitive associative learning (Brown et al.,
2012). These intracerebral infusion studies should be replicated by
regionally andneuronallymore speciﬁcmethods such as chemoge-
netics or optogenetics to avoid possible confounding infusion-site
diffusion to other regions and to various neuronal populations.
Furthermore, the brain circuitry for reward and aversion goes
well beyond the VTA, stressing the importance of systemic drug
experiments for translational relevance.
PLASTICITY OF GLUTAMATERGIC AND GABAergic
SYNAPSES
Growing evidence indicates that neuroadaptation (plasticity) in
the brain appears in both glutamatergic and GABAergic synapses
(for review, see Castillo et al., 2011; Luscher and Malenka, 2011;
Kullmann et al., 2012). Synaptic connections are highly plastic
and constantly modiﬁed by environmental factors and learning
tasks. It should be noted that generation of new glutamatergic and
GABAergic synapses proceeds under distinct mechanisms with
different factors regulating the processes (described below).
The major sites of contact for glutamatergic presynaptic ter-
minals are dendritic spines (Gray, 1959; Dailey and Smith, 1996;
Hering and Sheng,2001), and dynamic changes in themorphology
of dendritic spines have been associated with changes in synap-
tic strength (Segal, 2005). Spine morphology is subject to rapid
alteration by patterns of neuronal activity and by activation of
postsynaptic glutamate receptors (Lang et al., 2004; Matsuzaki
et al., 2004). Thus, synaptic efﬁcacy can be regulated by multiple
mechanisms.
Conversely, the predominant sites of contact for GABAer-
gic presynaptic terminals are not located on spines, but directly
on dendritic shafts (Freund and Buzsaki, 1996; Somogyi et al.,
1998). However, GABAergic system also interacts with synapses
on spines. Recent work has indicated that the activity of GABAA
receptors affects spine maturation (Heinen et al., 2003; Jacob et al.,
2009). In rat hippocampal cultures, reduced GABAA receptor
endocytosis (and increased activity) is associated with reduced
spine maturation and reduced levels of postsynaptic density
protein-95 (PSD-95; Jacob et al., 2009), and in the visual cortex
of adult GABAA receptor α1 subunit knockout mice (result-
ing in compensatory increased inhibition), the spine density is
reduced with a corresponding reduction in PSD-95 expression
(Heinen et al., 2003), results of both studies being in agreement
with GABAA receptor activation reducing LTP (Higashima et al.,
1998). Another study (Shen et al., 2010) showed that development-
dependent expression of α4 subunit-containing GABAA receptors
in dendritic spines of CA1 hippocampal neurons plays a role
in LTP induction. Notably, activation of these receptors reduces
depolarization that is needed to remove Mg2+ block of NMDA
receptors, thus leading to reduced LTP. Furthermore, a small
population of GABAergic interneurons that express somatostatin
makes synapses targeting directly on dendritic spine heads in
the mouse mPFC (Chiu et al., 2013), being able to control local
postsynaptic Ca2+ ﬂuxes within the spines. All these different
mechanisms indicate that the GABAA receptor activity may regu-
late rapid dynamics and long-term structural events in glutamate
synapses.
The strength of GABAergic synapses is determined by the size
of releasable pool of presynaptic GABA and number and/or diver-
sity of GABAA receptors sitting on postsynapticmembrane,which,
in turn, is largely determined by receptor trafﬁcking to and from
the plasma membrane, including receptor insertion, lateral dif-
fusion within membrane, removal, recycling and degradation
(Vithlani et al., 2011). Interestingly, high-resolution two-photon
imaging in organotypic hippocampal cultures has revealed that
new GABAergic synapses are formed by the appearance of new
boutons at pre-existing axon-dendrite crossings (Wierenga et al.,
2008). Hence, in that model, plasticity in GABAergic synapses
depends on the number of available axon-dendrite crossings,
which makes it more restricted than plasticity sites in glutamater-
gic connections. However, it is not known yet whether these
in vitro results can be generalized to all GABAergic synapses, and,
therefore, further in vivo studies are needed.
DRUG-INDUCED PLASTICITY OF GABAergic SYNAPSES
In addition to fast modulation of channel gating, both BZs and
neurosteroids have longer lasting effects by controlling the num-
ber and subtypes of GABAA receptors on the plasma membrane
(Vithlani et al., 2011; Deeb et al., 2012; Abramian et al., 2014).
Notably, treatment of hippocampal cultures with BZ agonist ﬂu-
razepam modulates GABAA receptor trafﬁcking by promoting
selective degradation of α2 subunit-containing GABAA receptors
after their removal from the postsynaptic membrane, leading to
a reduction in synapse size and number, and ﬁnally to depres-
sion of synaptic inhibition (Jacob et al., 2012). The development
of tolerance to the sedative effects of diazepam is associated with
a decrease in [3H]L-655,708 binding to the hippocampal den-
tate gyrus α5 subunit-containing receptors (dependent on α1
subunit-containing receptors), an effect which was extended by
the absence of tolerance in α5 subunit point-mutant mice (van
Rijnsoever et al., 2004). Treatment of C. elegans with the GABA-
site agonist muscimol also results in selective removal of GABAA
receptors from synapses (Davis et al., 2010). In contrast, neuros-
teroids can selectively enhance the trafﬁcking of extrasynaptic
GABAA receptors by insertion of new α4 subunit-containing
GABAA receptors into the membrane, resulting in an enhance-
ment of tonic inhibition in mice (Abramian et al., 2014). Thus, the
neuronal adaptations to GABAA drugs via modulation of receptor
trafﬁckingproduce long-lasting changes in the efﬁcacy of GABAer-
gic inhibition. However, it should be noted that the effects of
GABAA ligands on receptor subunits are very much dependent on
the experimental model, and the effects seen in cell culture models
have often been difﬁcult to reproduce in vivo (Uusi-Oukari and
Korpi, 2010).
The most obvious impediment to understanding neuroadap-
tation induced by GABAA receptor modulators is the diversity of
their target neurons. In fact, each neuron controlled by inhibitory
terminals expresses its unique combination of GABAA receptors
(Luddens et al., 1995; Olsen and Sieghart, 2009). A further obstacle
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to the studying of neuronal and structural drug-induced plastic-
ity is made by the fact that interneurons, as a major target for
GABAA receptor modulators, themselves are innervated by both
glutamatergic and GABAergic synapses. In addition, endogenous
GABAA receptor modulators, such as neurosteroids, whose lev-
els constantly ﬂuctuate, e.g., during stress, menstrual cycle and
development, can directly affect memory and learning processing
(Maguire et al., 2005; Shen et al., 2010), as well as inﬂuence the
action of other GABAA receptor modulators.
KCC2-MEDIATED SPINE MORPHOGENESIS
Potassium-chloride co-transporter 2 (KCC2) is expressed in neu-
rons to create the driving force for chloride ions to travel into
the cell through the GABAA receptor anion channel, which then
leads to hyperpolarizing GABA actions (Rivera et al., 1999). Inde-
pendently of its Cl− transport function KCC2 has also gained
attention due to its structural role in both glutamatergic and
GABAergic synapses (Li et al., 2007; Horn et al., 2010; Sun et al.,
2013). In glutamatergic synapses, KCC2 located in the neck and
head of dendritic spines binds to actin cytoskeleton via the linker
protein 4.1 N (Li et al., 2007). While the exact molecular mech-
anisms still remain elusive, the interaction of KCC2 with the
cytoskeleton is crucial for the maturation of spines and for the
stability of AMPA receptor clusters (Li et al., 2007; Gauvain et al.,
2011). In contrast to glutamatergic synapses, GABAergic synapses
are usually located directly on the dendritic shaft (Freund and
Buzsaki, 1996; Somogyi et al., 1998). KCC2 expression is regu-
lated by a cell adhesion molecule neuroligin-2 which is mostly
localized at GABAergic synapses. Knockdown of neuroligin-
2 down-regulates expression of KCC2 and reduces GABAergic
synaptogenesis, and interestingly, by affecting the KCC2 levels it
also down-regulates the number of glutamatergic synapses (Sun
et al., 2013).
Although there is no direct evidence yet on drug-induced
structural changes through KCC2-dependent mechanisms, sev-
eral studies demonstrated changes in expression levels of KCC2.
Chronic treatment with the BZ agonist zolpidem up-regulated
the KCC2 expression in mouse limbic forebrain (Shibasaki et al.,
2013). Also the neurosteroid allopregnanolone transiently modi-
ﬁes KCC2 expression and protein levels during brain maturation
in male rats (Modol et al., 2014). However, treatment with general
anesthetics,midazolam, propofol, and ketamine, does not alter the
expression of KCC2 in rats during the ﬁrst two postnatal weeks
when developmental maturation of KCC2 expression is going on
(Lacoh et al., 2013). Future studies should be directed to clar-
ify whether KCC2-mediated mechanisms play a role in neuronal
plasticity induced by GABAergic drugs (Kang et al., 2006), and
which particular isoforms of KCC2 play role in structural changes,
since a recent study suggests that KCC2a andKCC2b isoforms have
different brain regional distributions and likely different roles in
neuronal functions (Markkanen et al., 2014).
DRUG-INDUCED SYNAPTIC PLASTICITY IN THE VTA
The VTA has been widely studied given its fundamental role in
motivation and reward (for review, see Luscher and Malenka,
2011). VTA DA neurons project mainly to the NAc and mPFC and
less extensively to the hippocampus and amygdala. They receive
glutamatergic inputs from many brain regions, including the
mPFC, lateral hypothalamus, lateral habenula and hippocampus,
and in addition to local inhibitory control from theVTA GABAer-
gic interneurons, GABAergic inputs to DA neurons arise from the
NAc, ventral pallidum, nuclei of the extended amygdala, and ros-
tromedial tegmental nucleus (Jhou et al., 2009; Omelchenko and
Sesack, 2009; Watabe-Uchida et al., 2012).
Glutamatergic transmission in the VTA is critical to the rein-
forcing effects of drugs of abuse: suppressing the glutamatergic
transmission in the VTA attenuates cocaine and heroin reward
(Xi and Stein, 2002; You et al., 2007) and prevents the reinstate-
ment of cocaine- or heroin seeking (Bossert et al., 2004; Sun et al.,
2005). Glutamatergic synapses on VTA DA neurons can undergo
both NMDAR-dependent LTP and NMDAR-independent long-
term depression (LTD; Jones et al., 2000; Thomas and Malenka,
2003). Synaptic plasticity in the mesolimbic DA system was early
on hypothesized to play a role in the process of drug reinforcement
and addiction. During the last decade, evidence from electro-
physiological studies have accumulated showing that in addition
to acute activation of VTA DA neurons, drugs of abuse also
induce long-lasting plasticity in the synapses of these neurons.
Several classical drugs of abuse such as cocaine, amphetamine,
morphine, nicotine, and ethanol share the ability to induce an
NMDAR-dependent LTP at glutamatergic synapses of VTA DA
neurons via insertion of new GluA2 subunit-lacking AMPARs
(Ungless et al., 2001; Saal et al., 2003; Luscher and Malenka,
2011).
In addition to the potentiation of glutamatergic transmission,
different addictive drugs such as morphine, nicotine, cocaine, and
ethanol have been found to impair GABAergic transmission in the
VTA DA neurons by preventing the LTP of GABAergic synapses
(LTPGABA; Nugent et al., 2007; Guan and Ye, 2010). In the VTA,
LTPGABA is triggered by NMDA receptor activation at glutamate
synapses and requires nitric oxide-cGMP signaling (Nugent et al.,
2007; Nugent and Kauer, 2008). Blockade of LTPGABA could addi-
tionally increase release of DA by silencing local GABA neurons
(Liu et al., 2000; Nugent and Kauer, 2008; Niehaus et al., 2010).
Which particular GABAergic inputs are involved in LTPGABA and
whether the GABAA receptor modulators induce LTPGABA have
not been investigated so far.
GABAA RECEPTOR BENZODIAZEPINE-SITE DRUGS INDUCE
NEURONAL PLASTICITY IN THE VTA
Since the positive modulators of GABAA receptor benzodiazepine
site have well-known abuse potential and act as positive and/or
negative (Panlilio et al., 2005) reinforcers in different animal mod-
els of addiction, their effects on synaptic plasticity in VTA DA
neurons have been recently studied. Indeed, diazepam, and zolpi-
dem, similarly to the other drugs of abuse, were shown to induce
plasticity in the glutamatergic synapses contacting VTA DA neu-
rons (Heikkinen et al., 2009). Particularly, BZs induced an LTP that
was prevented by co-administration of the BZ antagonist ﬂumaze-
nil and by the NMDA receptor antagonist dizocilpine (MK-801;
Heikkinen et al., 2009). BZ-induced LTP in VTA DA neurons was
associated with insertion of new GluA2-lacking AMPA receptors,
and intra-VTA local network was sufﬁcient for the LTP induction
via inhibition of VTA GABAergic interneurons (Tan et al., 2010).
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Furthermore, Tan et al. (2010) examined amutantmousewithBZ-
insensitive α1 subunits, and found that in these mice midazolam
was not able to inhibit the ﬁring of VTA GABAergic interneurons,
to disinhibit the DA neurons, to induce plasticity at glutamatergic
synapses or to support drug-reinforcement behavior. This suggests
that the BZ-induced disinhibition of DA neurons is a key mecha-
nism involved in BZ-induced plasticity inVTA DA neurons as well
as in BZ reinforcement.
DRUGS TARGETING THE EXTRASYNAPTIC GABAA
RECEPTORS INDUCE VTA DA NEURON PLASTICITY BUT ARE
AVERSIVE
There is a need for new anxiolytic/sedative drugs with no abuse
potential. One approach has been to target a GABAergic system
separate from the benzodiazepine-sensitive GABAA receptors, i.e.,
the extrasynaptic GABAA receptors containing δ-subunit (Olsen
and Sieghart, 2009). However, δ-subunit is expressed along the
rewardpathway in theVTA,NAc,mPFC,andhippocampus (Pirker
et al., 2000; Hortnagl et al., 2013). THIP and muscimol, which act
on GABAA receptor agonist sites with preferential activation of
the high-afﬁnity extrasynaptic receptors (Chandra et al., 2010),
have been shown to increase ﬁring rates of DA neurons (Waszczak
and Walters, 1980). Thus, it was necessary to study the effects
of modulators of the extrasynaptic GABAA system on plasticity
in reward pathway and the possible reinforcing potential of these
drugs.
A single dose of THIP and another extrasynaptic GABAA
receptor modulator neurosteroid ganaxolone dose-dependently
induced similar AMPA receptor-mediated LTP in VTA DA neu-
rons via the primary action of increased tonic inhibition of VTA
GABAergic interneurons (Vashchinkina et al., 2012, 2014). Impor-
tantly, both THIP- and ganaxolone-induced plasticity lasted at
least for six days, while BZs cause this effect for three days only
(Heikkinen et al., 2009). The effects of THIP and ganaxolone
were absent in δ-GABAA receptor knockout mice, and both treat-
ments enhanced AMPA current rectiﬁcation, indicating reduced
targeting of GluA2 subunits.
Surprisingly, despite of aforementioned similar effects on neu-
roadaptations in VTA DA neurons, modulators of synaptic, and
extrasynaptic GABAA receptors induce distinct behavior in the
drug self-administration and place conditioning paradigms which
have been previously associated with activity of VTA DA neurons
(for review, see Luscher and Malenka, 2011). While activation of
the synaptic α1 subunit-containing GABAA receptors in the VTA
by oral midazolam is reinforcing in the self-administration, the
activation of extrasynaptic receptors by ip THIP or ganaxolone
leads to avoidance behavior as seen in conditioned place aver-
sion, and THIP is not self-administered either by mice or baboons
(Tan et al., 2010; Vashchinkina et al., 2012, 2014). These aversive
effects were abolished in GABAA receptor δ subunit-deﬁcient mice
(Vashchinkina et al., 2014), suggesting a speciﬁc role of this recep-
tor population in the VTA. These behavioral ﬁndings support the
hypothesis that activation of synaptic and extrasynaptic GABAA
receptors is rewarding and aversive, respectively. This may depend
on the primary brain areas targeted, as illustrated by intracere-
bral injections of muscimol (see below) that also preferentially
targets extrasynaptic receptors (Chandra et al., 2010). By using
place-conditioning system, muscimol infusion into the NAc shell
provoked conditioned place preference when infused anteriorly
and conditioned aversion when infused posteriorly (Reynolds and
Berridge, 2002). Intra-BLA infusions of muscimol and bicuculline
had no effect on reward (Zarrindast et al., 2004; Macedo et al.,
2006).
Furthermore, it is now becoming clear that aversive drugs or
experiences can acutely activate certain DA neurons in the VTA
and also induce a long-lasting potentiation at their glutamatergic
synapses. This was actually reported already in the early paper of
Saal et al. (2003) where the authors showed that in mice a 5-min
swimming stress at 6◦C water bath induces similar plasticity in the
VTA DA neurons as the classical drugs of abuse.
DO GABAA RECEPTOR DRUGS TARGET THE SAME
POPULATIONS OF VTA DA NEURONS?
DA neurons are divergent in many respects, e.g., in their elec-
trophysiological features, vulnerability to neurodegeneration and
regulation by neuropeptides (Korotkova et al., 2004; Lammel
et al., 2011). In particular, Lammel et al. (2011) have shown that
DA neurons in the mouse VTA are organized into anatomi-
cal and electrophysiological subpopulations inside the DAergic
nuclei depending on their projection terminal ﬁelds. However,
in rats, the VTA neurons might be more heterogeneously orga-
nized (Margolis et al., 2006, 2012). The inhibitory control from
VTA GABA interneurons is an important regulator of VTA DA
neuron activity and the following behavioral outcome. Aversive
stimuli have been shown to increase the ﬁring of VTA GABA neu-
rons (Creed et al., 2014). However, while GABA neurons in the
VTA seem to quite faithfully respond to aversion by excitation,
the responses in VTA DA neurons are more heterogeneous: acti-
vation, no response or inhibition have been observed in monkeys
(Matsumoto and Hikosaka, 2009). Rewarding or aversive stimuli
might modulate the activity of DA neurons differently depend-
ing on the brain area to which these neurons project. In mice, a
cocaine experience selectively affected DA cells projecting to the
NAc medial shell, while an aversive stimulus inﬂuenced DA cells
projecting to the PFC, and the DA neurons projecting to the NAc
lateral shell were modiﬁed by both rewarding and aversive stimuli,
suggesting that the mesocorticolimbic DA system is comprised of
anatomically distinct circuits, modiﬁed by different motivational
relevance (Lammel et al., 2011). In anesthetized rats, foot shock
inhibited DA neurons in the dorsal VTA, whereas the DA neurons
in the ventral VTA became phasically excited (Brischoux et al.,
2009). In mice, the majority of the VTA DA neurons decreased
ﬁring under fearful events, but a small group of DA neurons
were activated (Wang and Tsien, 2011). Another study reported
that a similar number of DA neurons were activated, inhibited or
unaltered by tail pinch, and it also showed that in mice with an
impaired NMDA receptor-mediated control of DA neurons the
DAergic activation in response to an aversive stimulus was atten-
uated, leading to impaired aversive conditioning (Zweifel et al.,
2011). These ﬁndings suggest that increases in DA signaling can be
evoked by stimuli with motivational relevance to either rewarding
or aversive direction, and they point toward putativemultiple pop-
ulations of VTA DA neurons with different afferent and efferent
connections.
www.frontiersin.org November 2014 | Volume 5 | Article 256 | 5
Vashchinkina et al. GABAAergic agonists and reward system
Mouse DA neurons with pronounced hyperpolarization-
activated cation current Ih-current are found in the lateral VTA
and they project to the lateral NAc shell, while the DA neurons of
the medial posterior VTA project to the mPFC and medial NAc
shell, and have no or very small Ih-currents (Lammel et al., 2011).
It should be noted that the study revealing BZ-induced gluta-
matergic plasticity in VTA DA neurons used a large Ih-current as
a marker for DA neurons (Heikkinen et al., 2009). Thus, mostly a
subpopulation of VTA DA neurons that projected to the lateral
NAc shell was studied. In the studies with THIP and ganax-
olone, a genetically modiﬁed mouse line with a ﬂuorescent protein
marker expressed in tyrosine hydroxylase-positive neurons was
used (Vashchinkina et al., 2012, 2014). This allowed recording
also from the DA neurons in more medial areas of the VTA with
small or no Ih-currents and projecting to the mPFC. It is possible
that BZs are positively reinforcing due to mainly activating and
modifying the DA neurons detecting reward whereas the drugs
activating the extrasynaptic GABAA receptors lead to conditioned
aversion because they activate and induce LTP in the DA neu-
rons involved in negative motivation. This hypothesis remains to
be carefully tested, although the post-study examination of the
recording sites for DA neuron plasticity by THIP failed to indicate
any anatomical localization within the VTA (Vashchinkina et al.,
2012).
Both BZs and extrasynaptic GABAA modulators produce
strong inhibition of theVTAGABA interneurons (Heikkinen et al.,
2009; Tan et al., 2010;Vashchinkina et al., 2012, 2014). Thus, a sim-
ilar disinhibitory mechanism is believed to induce the activation
and persistent modulation of VTA DA neurons by both classes of
GABAA drugs, which in turn suggests that they might be targeting
different populations of VTA GABA interneurons enriched with
synaptic and/or extrasynaptic GABAA receptors. Interestingly, a
recent study shows that the volatile solvent toluene, that also is a
positive modulator of GABAA receptors, induces LTP at the gluta-
matergic synapses ofVTADAneurons that project toNAc core and
shell, whereas it failed to affect the synapses of mPFC-projecting
neurons (Beckley et al., 2013). Importantly, toluene is abused by
humans, and in rodent models of addiction it increases ﬁring of
VTA DA neurons and DA release in the NAc and exhibits positive
reinforcement (Lee et al., 2006; Riegel et al., 2007; Lubman et al.,
2008). Effects of toluene on GABA interneurons have not been
studied so far.
In summary, the possible VTA heterogeneity of both the prin-
cipal DA neurons and the GABA interneurons and projection
neurons in responding to and mediating stimuli and affecting
behaviors is an important subject for future research. This infor-
mation would be needed to further develop rational treatment
ideas for addiction.
DRUG-INDUCED STRUCTURAL PLASTICITY IN THE VTA AND
ITS EFFERENTS
Midbrain (VTA and substantia nigra) and striatal (NAc and the
dorsomedial and dorsolateral striatae) components of the basal
ganglia and mesolimbic pathway are connected in a spiraling
manner so that ventral striatal regions project to medial parts
of the midbrain DAergic area, which subsequently sends projec-
tions to more dorsal striatal regions which in turn project to the
more lateral midbrain and so on (Haber et al., 2000). An appeal-
ing emerging hypothesis is that the initial drug-induced plasticity
in the DAergic midbrain and subsequently in the ventral stria-
tum would recruit more and more dorsal striatal regions during
chronic drug use and reinforce the connectivity within these spiral
projections, thus leading to compulsive drug-seeking manifesting
at the late stages of addiction (Grueter et al., 2012). The dorsome-
dial and the dorsolateral parts of striatum regulate goal-directed
and stimulus–response habitual movements, respectively (Yin and
Knowlton, 2006; Redgrave et al., 2010). The majority of the neu-
rons of ventral and dorsal striatum are projecting medium spiny
neurons (MSNs), whose activity depends to a great extent on exci-
tatory inputs from cortical and limbic regions (Sesack and Grace,
2010). Plasticity at excitatory synapses of the striatum would thus
change the output of striatal circuits, i.e., the motivated as well
as compulsive behaviors. Addiction seems to involve exceptionally
intense drug experience-driven synaptic and structural plasticity
at different levels of the mesolimbic DA system (Robinson and
Kolb, 1999).
GABAA receptor modulators are abused, but to date there are
no data available whether they are able to induce changes in neu-
ronal spine density in the reward system. Earlier work by Sarti
et al. (2007) demonstrated a correlation of cocaine-induced plas-
ticity of glutamatergic synapses with an increase in spine density
of the rat VTA neurons. In that work, the traditional Golgi-
Cox impregnation was used to study dendritic spines and cell
morphology was used to identify and subtype VTA DA neurons.
Since GABAA receptor modulators also induce similar glutamate
receptor neuroplasticity in VTA DA neurons, we were puzzled
with a question whether diazepam and/or THIP alter morphol-
ogy and spine density. At 24 h after single injections of the doses
of diazepam and THIP, which induce LTP in the VTA (Heikkinen
et al., 2009;Vashchinkina et al., 2012), the brains of mice were sub-
jected to Golgi staining and spine counting (Figure 1). In addition
to the VTA, we analyzed the hippocampal CA1 and CA3 regions,
since BZs are known to induce persistent synaptic plasticity par-
ticularly in the pyramidal neurons of the CA1 and CA3 regions
(Table 1).
We found that basal spine density counts in both hippocam-
pal and VTA neurons are in line with the results of (Sarti
et al., 2007). Treatment with THIP increased the spine den-
sity on the basal secondary dendrites of CA1 pyramidal cells
(Figure 1), but not in CA3 or VTA. In contrast, diazepam treat-
ment did not show any changes in spine density of the basal
dendritic spines in these areas, nor in the apical ones (data
not shown). This is generally consistent with a previous study,
in which acute and chronic treatment with BZs was not asso-
ciated with up-regulation of BDNF or c-Fos protein levels in
the hippocampus (Licata et al., 2013). Since Sarti et al. (2007)
found clear increase in VTA spines after neuroplasticity-inducing
dose of cocaine, our results suggest different mechanisms or dif-
ferent VTA DA neuron populations might have been involved
in the effects of various GABAA ligands. Additional studies
using retrograde neurotracers to clarify the targets and novel
immunoﬂuorescent co-staining methods for precise phenotyp-
ing of the neurons (Spiga et al., 2011) are needed to resolve
the affected VTA neurons. In spite of the comparable VTA
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FIGURE 1 | Pyramidal cells of hippocampal CA1 region exhibit distinct
morphological responses to diazepam andTHIP treatment.THIP
increased the spine density on the basal secondary dendrites of CA1
pyramidal cells (F2,15 = 9.69, p < 0.01), but not in CA3 or VTA (p > 0.05). In
contrast, diazepam (DZ) did not show any changes in spine density of the
basal nor apical dendritic spines in these areas (p > 0.05). On the left,
schematic neurons depict the spines either secondary or basal dendritic
branches that were assessed here. In the middle, representative images of
Golgi-stained neurons on horizontal sections. Insets are dendrites showing
spines. Scale bar is 10 μm. On the right, plots showing the spine densities
24 h after a single injection of DZ or THIP. Mean ± SEM for n = 10, 5, and 5
mice vehicle (Veh), DZ, andTHIP groups, respectively. **p < 0.01, (one-way
ANOVA followed by Bonferroni post hoc test). C57BL/6J mice (21–26 days
old) were decapitated at 24 h after treatment with DZ (5 mg/kg, ip), THIP
(6 mg/kg, ip) or vehicle (Heikkinen et al., 2009; Vashchinkina et al., 2012; All
animal procedures were approved by the Southern Finland Provincial
Government). Brains were rapidly dissected and immediately placed into
Golgi-Cox ﬁxative and processed using the FD Rapid GolgiStain Kit (FD
NeuroTechnologies). Impregnated brains were then cut in serial horizontal
80-μm-thick sections using a cryostat (Leica Microsystems, Nussloch,
Germany) and stained using the kit protocol. For each brain area, spine
density per 10 μm was assessed in ﬁve cells. Notably, in VTA cells spines
were determined on secondary dendrites, in CA1 and CA3 pyramidal cells
on basal dendritic branches, using the 100× objective of Zeiss Axioplan
microscope (Carl Zeiss MicroImaging GmbH, NA = 1.3, Ph3, DIC, oil), and
later analyzed by National Institutes of Health ImageJ software
(http://rsb.info.nih.gov/ij). Spine counting was performed blind concerning
the treatments. Only protrusions that show continuity with the dendritic
shaft were considered as spines.
neuroplasticity-inducing doses used, diazepam and THIP pro-
duced distinct effects on spine remodeling. These results show that
the acute effects of GABA-drugs are not consistently accompanied
by changes in spine densities of the dendrites in hippocampal or
VTA neurons.
Repeated exposure to cocaine has been shown to increase the
number of silent synapses and the density of dendritic spines in
NAc shell (Robinson and Kolb, 1999; Huang et al., 2009; Dobi
et al., 2011; Kim et al., 2011). Also dorsal striatum MSNs exhibit
an increased dendritic spine density following chronic cocaine
exposure (Ren et al., 2010). Months after repeated exposure to
methamphetamine the spine density increased in MSNs of the
dorsolateral striatum, a structure that supports habitual behav-
iors but decreased in dorsomedial striatum which is important
in goal-directed movements (Jedynak et al., 2007). A primate
study of chronic ethanol drinking reported increased spine den-
sity in the putamen (the primate analog of dorsolateral striatum
in rodents) as well as enhanced glutamatergic transmission and
increased intrinsic excitability of MSNs in this area (Cuzon Carl-
son et al., 2011). This pattern of structural plasticity in the dorsal
striatum supports the concept that during the progression of
addiction the behavior is driven toward habitual drug taking and
seeking.
Withdrawal from chronic treatment with addictive drugs leads
to hypofunction of VTA DA neurons. For example, withdrawal
from cannabinoids or morphine profoundly affects the mor-
phological characteristics of VTA DA neurons and spine density
of MSNs of the NAc shell (Spiga et al., 2003, 2010). Whether
chronic treatment with GABAA receptor modulators alters mor-
phology of VTA DA neurons or NAc and dorsal striatal MSNs,
with respect to addiction and/or withdrawal, remains to be
studied.
Broad distribution of GABAA receptors throughout the brain
suggests more widespread neuroplasticity effects of GABAA recep-
tor modulators in other brain regions such as the NAc, mPFC,
hippocampus, and amygdala (Licata and Rowlett, 2008). In fact,
several reports showed blockade of hippocampal LTP after acute
in vitro effects of BZs and isoﬂurane (summarized in Table 1).
This is consistent with the known effect of cognitive dysfunc-
tion induced by general anesthetics, and memory impairment by
BZs in humans (Canet et al., 2003; Newman et al., 2007). On the
other hand, withdrawal symptoms after repeated administration
of these drugs are associated with synthesis of new glutamater-
gic receptors and potentiation of LTP in the hippocampus and
cortex (Table 1). Thus, the glutamatergic receptors appear to be
regulated differently depending on the speciﬁc phase of the drug
effect.
CONCLUSION
GABAergic neurotransmission is known to participate in neuronal
plasticity processes during the critical periods in development,
and drugs acting on GABAA receptors, such as BZs, have
been considered more as blunting neuroplasticity than induc-
ing it. However, recent experiments on the midbrain dopamine
systems have revealed that GABAA drugs acting on different
receptor subtypes induce persistent neuroplasticity in glutamate
receptors of the VTA DA neurons, but so far there is little evi-
dence in support of widespread structural changes caused by
these drugs. The main mechanism of how the GABAA drugs
induce plasticity involves disinhibition via primary inhibition of
GABAergic interneurons. It is likely that more dynamic methods,
such as in vivo microscopy on dendritic spines, will be needed
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Table 1 | Summary of neuroplasticity induced by GABAA receptor drugs.
Brain area, cell type
(species)
Drug treatment Method Main findings Reference
Ventral tegmental area
Dopamine neurons
(mouse)
24–120 h after DZ (5 mg/kg),
THIP (6 mg/kg), ganaxolone
(30 mg/kg), zolpidem (5 mg/kg),
midazolam (0.5 mg/kg)
Electrophysiology Insertion of new GluA2-lacking
AMPA-Rs
Heikkinen et al. (2009),
Tan et al. (2010),
Vashchinkina et al.
(2012, 2014)
Nucleus accumbens
No data available
Cortex
Layer V pyramidal
neurons (rat)
96 h after diazepam for 14 days
at increasing doses
(17.6–70.4 μmol/kg)
IHC with
gold-immunolabeling
Up-regulation of GluA1 subunit of
AMPA-R’s mRNA and cognate
protein
Izzo et al. (2001)
Amygdala
Neurons of lateral
nucleus (mouse)
Short-term deep isoﬂurane
anesthesia
Electrophysiology Enhancement of capsaicin-induced
LTP viaTRPV1-mediated mechanism
Zschenderlein et al.
(2011)
Hippocampus
CA1 pyramidal neurons
(rat)
Withdrawal 96 h after DZ for
14 days at increasing doses
(17.6–70.4 μmol/kg)
IHC with
gold-immunolabeling
Up-regulation of GluA1 subunit of
AMPA-R’s mRNA and cognate
protein
Izzo et al. (2001)
CA1 pyramidal neurons
(rat)
Flurazepam-induced DZ
withdrawal
Electrophysiology Up-regulation of AMPA-R function Van Sickle et al. (2004),
Song et al. (2007), Xiang
andTietz (2007)
CA1, CA3 pyramidal
neurons, granule layer of
DG (rat)
Acute in vitro (5 μM) and in vivo
DZ and triazolam
Electrophysiology Inhibition of LTP del Cerro et al. (1992),
Mori et al. (2001),
Maubach et al. (2004),
Xu and Sastry (2005)
CA1 pyramidal neurons
(mouse)
In vitro isoﬂurane
(0.125-0.5 mM)
Electrophysiology Inhibition of LTD and LTP in
GABAAR- dependent manner,
nAChR α4β2 subtype-mediated
mechanism
Simon et al. (2001),
Haseneder et al. (2009)
CA1 pyramidal neurons
(mouse)
24 h–7 day after 2 h – isoﬂurane
anesthesia
Electrophysiology,
Western blotting
Enhancement of LTP via
up-regulation of GluN2B subunit of
NMDA-Rs
Rammes et al. (2009)
AMPA-R, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; CA, Cornu Ammonis, hippocampal areas; DG, dentate gyrus; DZ, diazepam; IHC,
immunohistochemistry; nAChR, nicotinic acetylcholine receptor; NMDA-R, N-methyl-D-aspartate receptor; THIP, gaboxadol.
to better understand the structural neuroplasticity/neurotoxicity
effects of general anesthetics, BZs and other types of anxiolyt-
ics and sedatives. Based on the present data, the selection of
an anesthetic agent will be important for these future experi-
ments!
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